The WTO waiver battle over Covid jab IP rights

Pharma federation IFPMA says US support for patent waiver ‘disappointing’
6 May 2021
European regulators urged to crack down on missing clinical trial results
6 May 2021

The WTO waiver battle over Covid jab IP rights

Sudden US backing for a global waiver on patent protections for COVID-19 vaccines offers hope to poor nations struggling for doses—but the big pharma industry thinks the notion misguided.

Comments are closed.